Cardiovascular Disease Rates Fuel Expansion Of POC Coagulation Testing Market: Transformative Forces Shaping the Point-of-Care (POC) Coagulation Testing Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Will the Point-of-Care (POC) Coagulation Testing Industry Market Size Be by 2025?
The market size of point-of-care (POC) coagulation testing has been experiencing robust growth in recent years. The market is projected to increase from $1.18 billion in 2024 to $1.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The surge in historical growth is linked to factors such as increased patient demand, the growing popularity of point-of-care testing, the high dependability of coagulation status on pt test, the incorporation of automation and electronic health records (EHRs), as well as the escalating occurrence of cardiovascular diseases and blood disorders.

What's the Long-Term Growth Forecast for the Point-of-Care (POC) Coagulation Testing Market Size Through 2029?
In the forthcoming years, the point-of-care (POC) coagulation testing market is projected to experience a stable surge in its size. The market is anticipated to reach $1.48 billion by 2029, progressing at a compound annual growth rate (CAGR) of 4.2%. The expansion projections for the forecast period can be linked to a broadening scope in healthcare, escalating needs in homecare environments, an uptick in chronic blood disorders, patients' preference for quick and precise testing, along with a boost in the point-of-care testing. During the forecast period, prime trends will include technological progression, a high demand in developed nations, widening applications in healthcare, the influence of COVID-19, and the rise of multiplexing POC diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

What Are the Key Growth Drivers Fueling the Point-of-Care (POC) Coagulation Testing Market Expansion?
The point-of-care (POC) coagulation testing market is set to grow due to the increasing prevalence of cardiovascular diseases. Disorders such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease fall under the umbrella of cardiovascular diseases (CVDs). These conditions affect the heart and blood vessels. POC coagulation testing plays a crucial role in the management of CVDs by providing instant data on coagulation status. This supports decisive action on coagulation measures, mitigating the chance of bleeding complications post-heart surgery. The World Heart Federation, a non-governmental organization based in Switzerland, reported in October 2022 that the mortality rate from cardiovascular disease may rise-death toll from CVDs estimated to increase from about 18.9 million in 2020 to more than 22.2 million by 2030, and could reach up to 32.3 million by 2050. Thus, with the increasing occurrence of cardiovascular diseases, the demand for point-of-care (POC) coagulation testing in the market is driving its expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

What Are the Key Trends Driving Point-of-Care (POC) Coagulation Testing Market Growth?
Leading organizations in the point-of-care (POC) coagulation testing sector are focusing on strategic alliances to secure a competitive advantage. These alliances are formal divulgations between two or more parties, with a focus on working cooperatively to reach specific, mutually beneficial objectives. For example, Jana Care, an American biomarker assay development company, entered into a strategic partnership with Roche Diagnostics, a Swiss firm known for developing diagnostic tests, tools, and digital health solutions. This alliance, formed in January 2023, is focused on creating and distributing a novel point-of-care blood testing platform intended for screening chronic kidney disease and heart failure. The revolutionary platform will offer patients the convenience of performing blood tests at home while clinicians can review the results remotely.

How Is the Point-of-Care (POC) Coagulation Testing Market Segmented?
The point-of-care (POC) coagulation testing market covered in this report is segmented -

1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care

Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp

Which Companies Are Leading the Charge in Point-of-Care (POC) Coagulation Testing Market Innovation?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

Which Regions Are Leading the Global Point-of-Care (POC) Coagulation Testing Market in Revenue?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.